Straumann Holding Ag

Corticalis As

Labrida As

Universitetet I Oslo

Lyngstadaas, S. Petter

Molenberg, Aaldert

S Petter Lyngstadaas

Aaldert Rens Molenberg

Jan Eirik Ellingsen

Johan Wohlfahrt

Hanna Tiainen

Havard J Haugen

Daniel Fehr

Aaldert (Aart) Molenberg

Roland Herzog

Håvard J Haugen

Johan Caspar Wohlfahrt

Aaldert Molenberg

Sébastien Francis Michel Taxt-Lamolle

The present invention is directed to a debridement and/or implant cleaning toolin which the means for cleaningis made of a biodegradable material. Thus, if parts of the means for cleaningcome loose during use, these will be degraded by natural processes in the body and will not remain in the body and cause negative body reactions.

Bio-resorbable debride or implant cleaning tool and method of manufacturing the same

The present invention is directed to a debridement and/or implant cleaning tool () in which the means for cleaning () is made of a biodegradable material. Thus, if parts of the means for cleaning () come loose during use, these will be degraded by natural processes in the body and will not remain in the body and cause negative body reactions.

The present document is directed to medical implants in the form of titanium dioxide scaffolds. Disclosed is a method for producing titanium dioxide scaffolds having an increased mechanical strength by recoating the titanium dioxide scaffold with a low viscosity titanium dioxide slurry in a vacuum infiltration process followed by sintering of the scaffold. The document is also directed to the recoated titanium dioxide scaffolds produced and their uses as medical implants.

Hard scaffold

The present document is directed to a titanium dioxide scaffold comprising a hydrogel coating comprising a biologically active substance. Also disclosed is a method for producing a thin hydrogel coating on a titanium dioxide scaffold and uses of the hydrogel coated scaffolds as medical implants.

Hydrogel coated scaffold

A kit having a) a cleaning device, the cleaning device () including an elongated base member () formed of at least two wires () being twisted with each other, and a plurality of bristles () fixed between the twisted wires () and extending away from the twisted wires (), whereby the bristles () are positioned in a cleaning section () at a first end () of the base member (); wherein the bristles () consist of titanium or a titanium alloy; and b) a container having a composition including ethylene diaminotetraacetic acid (EDTA) is disclosed. A method for cleaning and/or debriding and/or conditioning a biological mineralized surface and/or a biological soft tissue surface and/or a dental implant is also disclosed. Additionally, there is disclosed a method for preventing and/or treating a condition in a patient in need of such treatment.

Medical cleaning kit

A low-concentration formulation of an active enamel substance, such as an enamel matrix, enamel matrix derivative and/or an enamel matrix protein, is intended to be used as a therapeutic, as a prophylactic and/or as a cosmetic agent. The active enamel substance is incorporated into a polymeric matrix, which is either suitable for cellular in-growth, or is cell-occlusive, so that it is released by degradation of the polymeric matrix, by enzymatic action and/or by diffusion. A new pharmaceutical and/or cosmetic formulation of an active enamel substance is provided at a lower total concentration within the formulation, wherein a spatial and/or selective regulation of release of said active enamel substance permits a greater percentage of the active enamel substance to be released at the time of appropriate cellular activity.

Protein formulation

The present invention relates to a new and improved low-concentration formulation of an active enamel substance, such as an enamel matrix, enamel matrix derivative and/or an enamel matrix protein, intended to be used as therapeutic, as propylacetic and/or as cosmetic agent. In the present invention, said active enamel substance is incorporated into a polymeric matrix, which is either suitable for cellular in-growth, or cell-occlusive. The active enamel substance can be incorporated into the polymeric matrix so that it is released by degradation of the polymeric matrix, by enzymatic action and/or by diffusion. Comprised in the invention is thus in particular a new pharmaceutical and/or cosmetic formulation of an active enamel substance at a lower total concentration within the formulation, wherein a spatial and/or selective regulation of release of said active enamel substance permits a greater percentage of the active enamel substance to be released at the time of appropriate cellular activity.

Growing community of inventors

Nesoddtangen, Norway

S Petter Lyngstadaas